White label ELPA - ClinicalTrials.eu

Study of Ziftomenib (KO-539) in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Not recruiting

2 1 1
Investigated Diseases:
- Acute myeloid leukaemia recurrent
Investigated Drugs:
- Ziftomenib
Study on the Long-term Effects of Dupilumab in Preventing Lung Function Decline in Adults with Uncontrolled Moderate to Severe Asthma

Not recruiting

3 1
Investigated Drugs:
- Dupilumab
+1
Comparison of Nilotinib versus Imatinib treatment in newly diagnosed chronic myeloid leukemia patients to achieve treatment-free remission

Not recruiting

3 1 1 1
Investigated Drugs:
- Nilotinib
- Imatinib
Study of Daratumumab Injections for Patients with Moderate to Severe Chronic Fatigue Syndrome

Not recruiting

2 1 1 1
Investigated Diseases:
- Chronic fatigue syndrome
Investigated Drugs:
- Daratumumab
Study Comparing Bictegravir/Lenacapavir to Current Therapy in People with HIV-1 Who Are Successfully Treated

Not recruiting

3 1 1
Investigated Diseases:
- HIV infection
Investigated Drugs:
Study on Pembrolizumab for Patients with High-Risk Stage III Melanoma After Surgery

Not recruiting

3 1 1
Investigated Diseases:
- Malignant melanoma stage III
Investigated Drugs:
- Pembrolizumab
+7
Study on the Effectiveness and Safety of Avalglucosidase Alfa for Babies with Infantile-Onset Pompe Disease

Not recruiting

3 1 1 1
Investigated Diseases:
- Glycogen storage disease type II
Investigated Drugs:
- Avalglucosidase Alfa
Study on the Effects of Pemafibrate and Tofogliflozin in Patients with Nonalcoholic Steatohepatitis (NASH) and Liver Fibrosis

Not recruiting

2 1
Investigated Drugs:
- Pemafibrate
- Tofogliflozin
Study on the Effectiveness and Safety of Mitapivat in Children with Pyruvate Kinase Deficiency Not Receiving Regular Blood Transfusions

Not recruiting

3 1
Investigated Diseases:
- Pyruvate kinase deficiency anaemia
Investigated Drugs:
- Mitapivat
Study of DYNE-251 safety and effectiveness in patients with Duchenne muscular dystrophy who are candidates for exon 51 skipping treatment

Not recruiting

2 1
Investigated Diseases:
- Duchenne muscular dystrophy
Investigated Drugs:
- Fragment Antibody Targeting Human Tfr1 Conjugated To Phosphorodiamidate Morpholino Oligomer

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies